Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

EOR Family med > OB/GYN > Flashcards

OB/GYN Flashcards

1
Q

leading cause of CA death in women worldwide

A

breast CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

USPSTF screening breast CA

A

b/l screening mammography for women at normal risk at 50 years and repeating q 2 years until pt is 74 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

“high risk” for breast CA

A

first degree relative w breast CA
Hx of radiation therapy to the chest btwn ages 10 and 30
ancestry associated w increased incidence of BRCA1 and BRCA2
known hereditary breast or ovarian CA syndrome
Hx of breast, ovarian, peritoneal, tubal CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Screening recs for breast CA for high risk

A

annual MRI o the breasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MC type of breast CA

A

invasive ductal carcinoma
infiltrating lobular carcinoma (2nd)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

classic presentation of breast CA

A

hard, immobile breast mass

advanced dz:
axillary lymphadenopathy
skin changes (dimpling or ulceration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

RF for breast CA

A

advanced age
obesity
high estrogen
dense breast tissue
insulin resistance
in utero exposure to diethylstilbestrol (DES)
hormone replacement therapy after menopause
pregnancy at advanced age
nulliparous women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MC benign breast condition

A

fibrocystic breast disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

who does fibrocystic breast disease usually affect

A

premenopausal women between 30 and 50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

characterization of fibrocystic breast disease

A

multiple painful, swollen, mobile, lumpy, and well-circumscribed masses in both breasts that appear before menses and resolve with the start of the menstrual cycle

may have serous nipple discharge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

aspiration of fibrocystic breast disease

A

straw-colored fluid without blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

only FDA approved tx for fibrocystic breast disease

A

Danazol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

fibroadenoma

A

MC breast tumor in young women
painless, solitary, smooth, firm, mobile, rubbery, well-defined mass

does not wax and wane w menstruation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

imaging for nontender breast mass in pts < 30 – basically if breast mass is unknown but not necessarily suspicious for malignancy - what should you do first

A

US (of whichever breast)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when do HPV infections usually resolve

A

within 12 mos - if longer, more likely cancerous or precancerous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

RF cervical CA

A

early age of sexual activity
multiple partners
hx of STI
hx or vaginal or vulvar neoplasia/CA
low socioeconomic status
immunosuppression (think HIV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

two major types of cervical CA

A

squamous cell (MC)
adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

progesterone only options contain

A

Levonorgestrel
Norethrindrone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

cystocele

A

posterior bladder wall herniates through the anterior wall of the vagina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

sx cystocele

A

feeling of fullness/bulge in vaginal area worse w abdominal pressure (valsalva) and better w rest
urinary incontinence
more frequent UTI
pt may leak urine if asked to cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

tx for cystocele

A

supportive if sx don’t bother pt
pessary if sx bother patient
surgery is definitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

menorrhagia

A

blood loss > 80 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what should be considered in ppl w menorrhagia

A

coagulation studies

24
Q

PALM-COEIN

PALM = structural
COEIN = nonstructural

A

Polyps
Adenomyosis
Leiomyoma
Malignancy
Coagulopathy
Ovulatory dysfunction
Endometriosis
Iatrogenic
Not yet classified

25
Q

prenatal visits

A

q 4 weeks from 4-28 weeks gestation
q 2 weeks from 28-36 weeks gestation
weekly after 36 weeks

26
Q

what should be assessed at each prenatal visit

A

weight
BP
fetal heart rate
urinalysis
glucose
presence of fetal movement
presence of vaginal bleeding

27
Q

when do you assess fundal height

A

at each visit starting at 20 weeks

28
Q

screening for defects

A

15-24 weeks gestation

29
Q

6-12 weeks gestation testing

A

random blood glucose
CBC
serologic test for syphilis, rubella antibody titer, varicella antibody titer, HIV testing, ABO and RH typing with antibody screen, Hep B surface antigen, sexually transmitted infection screening for chlamydia

30
Q

maternal quad screen

A

alpha fetoprotein
hCG
estradiol
inhibin A

31
Q

when is anatomical US performed

A

18-20 weeks

32
Q

screening for gestational DM and anemia

A

24-28 weeks

33
Q

pts who are RH negative

A

anti-D immunoglobulin at 28 weeks

34
Q

unopposed estrogen in a women with intact uterus

A

increased risk of endometrial CA and endometrial hyperplasia

35
Q

severe critical PID

A

high fever
N/V
severe pain
abscess
perihepatitis
pregnancy

36
Q

combo therapy PID

A

one time IM injection of Ceftriaxone
14 days of oral doxy and metronidazole

37
Q

tx PID if doxy not well tolerated

A

7 day course Azithromycin

38
Q

cystocele versus rectocele

A

cystocele - smooth mass w vaginal rugae protruding from the anterior vaginal wall
rectocele - smooth mass w vaginal rugae protruding from the posterior vaginal wall

39
Q

spontaneous abortion

A

pregnancy loss before 20 weeks of gestation

40
Q

RF spontaneous abortion

A

> 35
prior pregnancy loss
substance use (tobacco, caffeine, alcohol, illicit substances)
subchorionic hemorrhage
stress
DM
obesity’ thyroid disease
inherited thrombophilias
presence of IUD during pregnancy

41
Q

sx spontaneous abortion

A

crampy lower abdominal pain
uterine bleeding

42
Q

what is recommended for all women undergoing a spontaneous abortion

A

uterine US
serial quantitative beta-human chorionic gonadotropin levels

43
Q

threatened spontaneous abortion

A

cervical os closed
no passage of fetal tissue

44
Q

inevitable spontaneous abortion

A

cervical os opened
no passage of fetal tissue

45
Q

incomplete spontaneous abortion

A

cervical os open
there is passage of fetal tissue (some still remain in uterus)

46
Q

complete spontaneous abortion

A

cervical os is closed
complete passage of fetal parts and placenta
uterus contracted

47
Q

missed spontaneous abortion

A

in utero death
cervical os closed
non passage of fetal tissue

48
Q

septic spontaneous abortion

A

infection of uterus
open with purulent cervical discharge and uterine tenderness
no passage (may be incomplete)

49
Q

trichomoniasis

A

protozoan parasite trichomonas vaginalis

50
Q

sx trichomoniasis

A

increased malodorous discharge
dysuria
urinary frequency
dyspareunia
vaginal itching/irritation
greenish/yellow vaginal discharge
friable cervical mucosa (strawberry cervix)

51
Q

wet mount (saline microscopy) trich

A

flagellated motile trichomonads
ph > 5

52
Q

tx trichomoniasis

A

Metronidazole 2 g PO single dose or 500 mg twice daily for 7 days

53
Q

Bacterial vaginosis

A

vaginal discharge that is thin, milky, white-gray and a fishy odor

54
Q

saline wet mount for BV

A

epithelial cells covered by bacteria (clue cells)

55
Q

tx bacterial vaginosis

A

metronidazole 500 mg twice daily for 7 days (safe in pregnancy)

EOR Family med (25 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions